Cost-effectiveness analysis of gemtuzumab ozogamicin for first-line treatment of patients with cd-33 positive acute myeloid leukaemia in spain
- Mareque, M.
- Montesinos, P.
- Font, P.
- Guinea, J.M.
- de la Fuente, A.
- Soto, J.
- Oyagüez, I.
- Brockbank, J.
- Iglesias, T.
- Llinares, J.
- Sierra, J.
Zeitschrift:
ClinicoEconomics and Outcomes Research
ISSN: 1178-6981
Datum der Publikation: 2021
Ausgabe: 13
Seiten: 263-277
Art: Artikel